citation_index
TL2 Member · Cologne, DE
Keeps a personal log and shares the numbers when they are relevant, with the measurement caveats attached.
Joined 19 September 2025 · last posted 15h
91Posts here
2Topics
0Solutions
168Likes received
151Likes given
15Badges
137Days visited
1.2kPosts read
Stated areas
Recent activity
Full stream-
Restarting after a long gap: what the labelling implies Replied, post #47 · Practice › Dosing & titration · 27 Jul 2026 · 0 likes This follows post #44 rather than contradicting it. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the…
-
Here for the analytics and not much else Replied, post #93 · Lounge › Introductions · 26 Jul 2026 · 0 likes If you are arriving from somewhere louder, the pace here will feel slow. A topic can sit for two days and then get a reply that is worth the wait. That is the design…
-
What a certificate commits its issuer to Replied, post #103 · Analytics › COA interpretation · 25 Jul 2026 · 2 likes Post #102 is the version of this I will quote in future. One addition. The distinction between release testing and characterisation is one industrial documents make and…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #70 · Clinical › Prescriber conversations · 24 Jul 2026 · 19 likes Adding a data point of agreement rather than a data point.
-
Follow-up: How compounding permissions changed when supply normalised Replied, post #60 · Sourcing › Regulatory · 23 Jul 2026 · 8 likes Everything in post #56 holds. The case it does not cover is the one I have. Where I have landed on compounding permissions, having got it wrong once in public: the…
-
Follow-up: Signs of dehydration worth acting on Replied, post #35 · Safety › Adverse events · 23 Jul 2026 · 20 likes Careful with the language on Signs of dehydration worth acting. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
What is genuinely unknown about long-term amylin agonism Replied, post #69 · Compounds › Cagrilintide & amylin analogues · 22 Jul 2026 · 22 likes Research-use-only cagrilintide is not approved for human use and the published evidence base is a clinical-trial evidence base. Those two facts sit uncomfortably…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #78 · Analytics › Home & field testing · 16 Jul 2026 · 0 likes Picking up post #77: that is the part I would want checked first. A home refractometer is not measuring what people hope it is measuring in these preparations, and the…
-
Travelling with an injectable: documentation and practicalities Replied, post #40 · Access › International · 14 Jul 2026 · 22 likes Regional practice around what a pharmacy will and will not do varies enormously and is not deducible from the regulatory position.
-
Tracking intake honestly when appetite is absent Replied, post #96 · Nutrition & Training › Protein & intake · 13 Jul 2026 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #3 · Compounds › Tirzepatide · 12 Jul 2026 · 0 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
-
What a certificate commits its issuer to Replied, post #6 · Analytics › COA interpretation · 9 Jul 2026 · 22 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…